Getting your people proposition right is crucial to the success of an early-stage business.
Your people are one of your most valuable assets - they will help grow your company and achieve your long-term strategy. A comprehensive workforce strategy is vital in attracting and retaining the right talent to drive this success and growth. This is true whether your longer-term aim to secure further funding or enhance value with a view to making a strategic disposal later down the line.
We have a wealth of experience in working with venture clients to develop their workforce strategy. Our experts can translate business intelligence acquired during a due diligence process, together with our sector experience and understanding of the issues on the horizon, to help you develop a workforce strategy consistent with your ESG and CSR goals.
Making sure that your workforce is on a sound legal footing also brings value, as employment law missteps can be costly. Our venture capital employment specialists are on hand to help venture capital funds, their portfolios and their management teams navigate the ever-changing employment landscape.
In today's world it is vital that relationships, information, assets and opportunities generated by your workforce are protected and belong to the company. Our team can help put your business on the strongest footing from bespoke restrictive covenants and confidentiality provisions through to IP and professional networking/ social media restrictions. When a key individual leaves, we can immediately help you to assess the threat and take action to minimise the risks to your business and reputation.
Our team also help companies sitting on the other side of the fence too - from successfully arguing restrictions are not enforceable all the way through to advising on the best ways to onboard restricted employees and their teams and expanding client bases.
Find out more about protecting your business >
Contingent worker arrangements
Many start-ups need to be flexible with their labour requirements. You might need to hire consultants to deliver a particular project or agency workers to supplement your workforce at times of high demand. Our team has a deep understanding of the issues and requirements around using contingent workers and are experts on managing the labour law, tax and regulatory risks around them. We regularly advise on IR35, employee/worker status, agency workers, intermediaries or umbrella companies and PEOs.
Find out more about contingent worker arrangements >
In a globally competitive environment, you will want to recruit the best people wherever they are in the world. Our immigration team can support you and your key individuals, ensuring they are able to enter or remain in the UK, as well as assist with the requirements of your business visitors. We have considerable experience in helping business develop and implement international agile working arrangements from an employment, data protection, health & safety, taxation and immigration perspective.
Learn about our bespoke fixed price business immigration solutions >
When you are busy focusing on your core business, it's important to remember your legal obligations to your employees and the corporate governance issues that need to be considered as part of the workforce strategy.
We can help you:
- put in place the employment contracts and policies you need;
- navigate complex employment-related data protection legislation;
- make sure you comply with equal opportunities obligations and avoid discrimination claims;
- identify your health and safety obligations;
- implement best practice to promote wellbeing and avoid burnout in your workforce; and
- help to reduce the reputational risk that can arise from a disgruntled employee or failure to implement appropriate whistleblowing safeguards.
Work highlights from across the ventures ecosystem
We advised AlbionVC as the world's first cybersecurity human risk management platform, OutThink, which combines machine learning, natural language processing and applied psychology to identify individuals' attitudes and behaviours, has raised £8.8 million in its latest funding round.
We advised AlbionVC as Toqio has secured £17.2m in Series A funding, which also includes a £1.1m grant from a public organisation for technology development in Spain.
Argonaut Therapeutics Ltd
We advised Argonaut Therapeutics Ltd on its merger with Celleron Therapeutics Ltd.
We advised Foresight, a leading listed regional private equity and infrastructure investment manager, on the first close of its Foresight Scotland Fund.
UCL Technology Fund
We advised UCL Technology Fund on lead investment in Bloomsbury Genetic Therapies' £5 million financing round.
We advised BGF on its investment in autonomous vehicle software global leader Oxbotica's Series C funding round raising US$140 million. The funding will be used to drive Oxbotica's global expansion and accelerate commercialisation of its technology.
We advised digital health startup Mediktor in an 11m euro series B round led by Swiss fund MTIP. We already advised Mediktor in their 3m euro series A round led by Alta Life Sciences.
We advised on the establishment of Giant Ventures and the launch of its Fund I and Fund II.
We advised Barcelona-based HR SaaS developer Factorial in an $80m series B finance round, led by Tiger Global, with co-investment by funds Creandum and CRV.
Mangrove Capital Partners and 14W
We advised Mangrove Capital Partners and 14W as lead investors in a $30m finance round in online travel agency Exoticca.
Accel and 14W
We advised Accel and 14W on an $181m series F funding round led by Korelya as investors in second-hand marketplace Wallapop.
Advised a transatlantic syndicate of top-tier life sciences investors including Advent Life Sciences, CTI Life Sciences, Cambridge Innovation Capital and Fonds de solidarité FTQ in US$13.6 million funding round.
Pink Salt Ventures
We advised on the establishment of Pink Salt Ventures and the launch of its first fund.
Advised pioneering AI lung cancer diagnosis innovator Optellum on US$14m Series A funding round.
Advent Life Sciences
We advised Advent Life Sciences, one of the leading transatlantic venture investors building innovative life sciences businesses, on its lead investment in Proximie's US$80 million Series C funding round.
We advised Super Payments on its £22.5 million fundraise led by Accel to transform the online shopping experience.
Advised Causeway Technologies on a £120 million investment to fund strategic acquisitions and accelerate its organic growth strategy to digitally connect the construction supply chain through further development of its Cloud Platform.
Highland Europe and Frog Capital
We advised Highland Europe and Frog Capital on additional investment in Modulr an embedded payments platform for digital businesses.
We advised on the launch of the Foresight Williams joint venture (and Foresight Williams EIS Fund).
Advised Highland Europe on its series C$100 million investment in SaaS platform Plentific.
We advised Fintern on fundraising as it secures £40 million of capital. Investment will help scale its credit technology and power fair finance across the UK and beyond.
We advised Nexeon on significant US$80 million funding to scale up production of step change battery materials. Through the transaction, Nexeon enters into a strategic partnership with SKC, a major global battery and semiconductor
We advised Eight Roads on its lead in 7bridges' $17 million Series A fundraising round. Eight Roads led the round together with Local Globe and enterprise VC Crane. With this round 7 bridges has raised just over $20 million to date.
Osborne Clarke has advised DoorDash on USD 750 million Series B financing round of rapid delivery firm Flink SE.
Warburg Pincus and Hollyport Capital
Osborne Clarke advised Warburg Pincus and Hollyport Capital on Series D financing round of McMakler.
We advised Tiger Global on its lead investment in Lifebit's $60 million series B funding round. The round will field the rapid adoption of biomedical software around the world. We advised Tiger Global on its lead investment in Lifebit's $60 million series B funding round. The round will field the rapid adoption of biomedical software around the world.
Science Creates Ventures, Foresight Williams Technology and BGF
We advised Science Creates Ventures, Foresight Williams Technology and BGF on their involvement in Forefront RF's initial £1.5 million investment round, which also included The Cambridge Angels.
We advised Flock on $17 million fundraise led by social capital to reinvent insurance for connected vehicles. A funding to supercharge its expansion into new geographies and product lines.
We advised BGF on its lead investment in a £58 million funding of disruptive femtech firm Elvie, the revolutionary global health and lifestyle brand developing iconic products for women.
We advised on the launch of Passion Capital's third venture fund.
We advised Element Ventures, a global venture capital fund, as the lead investor in Coincover's $9.2 million Series A round. The funding will be used to drive awareness of the product offering and grow the team so that Coincover can support more of the crypto market.
We advised NeRRe Therapeutics on its £20 million Series B2 financing round. The financing involved a syndicate of leading transatlantic life sciences investors led by new investor Columbus Venture Partners and existing investors Advent Life Sciences, Fountain Healthcare Partners, Forbion Capital Partners and OrbiMed.
BGF and CPT Capital
We advised BGF and CPT Capital on a £11 million equity fundraising round for THIS, a plant-based, meat alternative brand.
We advised digital onboarding platform, Thirdfort, on its latest £1.5 million fund raising. Leading digital entrepreneur Alex Chesterman is among the high profile names to have reinvested. The funding will support expansion in the legal and property sectors for the digital ID and anti-money-laundering start up.
Illuminate Financial Management
We advised on the launch of all of Illuminate's funds (three in total), focusing on early-stage investments in the global capital markets Fintech market.
We advised BGF on a £10.5 million minority investment in e2e-assure, an established, fast-growth cybersecurity. The Funding will be used to facilitate international growth and expand its go-to marketing offering.
Science Creates Ventures
We advised on the establishment of Science Creates Ventures and the launch of its first fund.
We advised Amphista Therapeutics, a leader in next generation targeted protein degradation (TPD) approaches, on its $53 million (£38 million) Series B financing round.
We advised Brazilian venture capital manager Monashees, on its lead investment in AI energy analytics start-up Vortexa's $19m Series B investment round.
We advised firstminute capital on the launch of firstminute capital I, and firstminute capital II as well as series of SPV LP's.
Clean Growth Fund
We advised the Clean Growth Fund on a £6 million co-investment with Gulf Oil in Indra, the UK's leading smart charging technology company.
We advised on the launch of the second early-stage technology fund from firstminute capital raising $111 million to date.
We advised BFG on its £6 million investment in Amdaris, an industry-leading software developer and digital transformation specialist, to support its organic and acquisitive growth strategy.
We advised InReach on the launch of their first fund targeting seed and pre Series A investments in European technology companies
We advised MMC on the launch of the MMC Greater London Fund and the MMC Scale up Fund 2019 as well as a series of SPV LP's.
We advised on the the launch of all of Notion's UK-based venture and growth capital funds.
We advised on the launch of PiLabs' third European proptech fund.